Keywords: extra, aes, gsk, once-daily, pd, drug, uk

No extra AEs for GSK's once-daily PD drug

Article | 11 September 2006

Print This

UK drug major GlaxoSmithKline says that new data demonstrate that a prolonged-release, once-daily, formulation of ropinirole is at least as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in